Botulinum Toxin Injection for Preventing Secondary Atrial Fibrillation in Patient With Supra-ventricular Tachyarrythmias

Supra-ventricular Tachyarrhythmias Clinical Trial

Status Recruiting

Clinical Trial Summary

The investigators have conducted a prospective, double-blind, randomized study to assess the comparative safety and efficacy of two different ablation strategies, RFA versus RFA plus botulinum toxin injection, in patients with supra-ventricular tachyarrhythmias. Results were assessed with the use of an implanted monitoring device (IMD).

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Treatment

Related Conditions & MeSH terms

• Supra-ventricular Tachyarrhythmias
• Tachycardia, Ventricular

• NCT number: NCT02008461
• Study type: Interventional
• Source: Meshalkin Research Institute of Pathology of Circulation
• Contact: Evgeny Pokushalov, MD, PhD
• Phone: +79139254858
• Email: e.pokushalov@gmail.com
• Status: Recruiting
• Phase: Phase 2
• Start date: June 2013
• Completion date: February 2016